Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 7,814

Sort by:

North America: Vitamins Market US$ 1,999.00

... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...

July 2021 150 pages

Global Cephalosporin Drugs Market Size study, by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), by Prescription Type (Prescription Drugs and OTC Drugs), and Regional Forecasts 2021-2027 US$ 4,950.00

Global cephalosporin drugs market is valued approximately at $14.1 billion in 2020 and is anticipated to grow with a healthy growth rate of about 2.6% over the forecast period 2021-2027. Cephalosporin...

July 2021 200 pages

Antibiotics Markets in China US$ 4,000.00

China's demand for Antibiotics has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

July 2021 267 pages

Antibiotics Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Antibiotics industry forecasts. In the two past decades, the ... long-term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...

July 2021 94 pages

Antibiotics Companies in China US$ 1,800.00

This study focuses on China’s Antibiotics industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

July 2021 123 pages

U.S. OTC Drugs Market - Industry Outlook & Forecast 2021-2026 US$ 3,750.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. OTC Drugs Market Report The U.S. OTC drugs market by revenue is expected to grow at a CAGR of 4.01% during th...

July 2021 180 pages

Investigation Report on China's Atorvastatin Market 2021-2025 US$ 2,600.00

Atorvastatin is a statin drug, which is used to lower blood cholesterol levels. This common drug is mainly used to treat high cholesterol, hyperlipidemia, and coronary heart disease. The original drug...

July 2021 50 pages

Investigation Report on China's Capecitabine Market 2021-2025 US$ 2,600.00

Capecitabine is a pyrimidine analog (pentoxycarbonyl-deoxy-cytosine nucleoside) that has anti-tumor activity to inhibit a variety of solid tumors, including breast and colon cancer. Capecitabine was d...

July 2021 50 pages

Investigation Report on China's Caspofungin Market 2021-2025 US$ 2,600.00

Caspofungin is the first echinocandin antifungal drug. It has a broad antibacterial spectrum, a long half-life, a high binding rate to human serum proteins, and a few adverse reactions. It is known as...

July 2021 50 pages

Investigation Report on China's Hemocoagulase Market 2021-2025 US$ 2,600.00

Hemocoagulase, developed by Swiss Sugo Pharmaceuticals, is a high-purity, single-component hemagglutinin clinical hemostatic drug. Its original drug is called REPTILASE, which is not on the market in...

July 2021 50 pages

Investigation Report on China's Iohexol Market 2021-2025 US$ 2,600.00

Iohexol is a non-ionic X-ray contrast agent. Iohexol injection is suitable for intravascular and intracavitary injections in adults and children. In clinical angiography (cerebrovascular angiography,...

July 2021 50 pages

Investigation Report on China's Linezolid Market 2021-2025 US$ 2,600.00

Linezolid is an oxazolidinone antibiotic, mainly used to treat infections caused by gram-positive (G+) cocci, including suspected or confirmed hospital-acquired pneumonia (HAP) caused by methicillin-r...

July 2021 50 pages

Investigation Report on China's Metformin Market 2021-2025 US$ 2,600.00

Metformin is the first-line drug for the treatment of type 2 diabetes, especially in people who are overweight. Metformin was originally developed by Merck Sharp & Dohme (trade name: GLUCOPHAGE ). GLU...

July 2021 50 pages

Investigation Report on China's Mycophenolate Mofetil Market 2021-2025 US$ 2,600.00

Mycophenolate mofetil is a powerful inhibitor of lymphocyte proliferation and has been used to prevent acute rejection of allografts since the early 1990s. Mycophenolate mofetil is also widely used as...

July 2021 50 pages

Investigation Report on China's Nicergoline Market 2021-2025 US$ 2,600.00

Nicergoline is a kind of ergot derivative, used to treat Alzheimer's disease and other vascular diseases, originally researched by Pfizer Pharmaceuticals. Since its successful development in the 1960s...

July 2021 50 pages

Investigation Report on China's Nifedipine Market 2021-2025 US$ 2,600.00

Nifedipine is a dihydropyridine calcium channel blocker, which is mainly used to bind to L-type calcium channels. Nifedipine is mainly used to treat chronic stable angina pectoris, vasospasm angina pe...

July 2021 50 pages

Investigation Report on China's Octreotide Market 2021-2025 US$ 2,600.00

Octreotide is a derivative of artificially modified natural somatostatin, which is an octapeptide. Its physiological effects include inhibiting growth hormone function, inhibiting the secretion of gas...

July 2021 50 pages

Investigation Report on China's Pregabalin Market 2021-2025 US$ 2,600.00

Pregabalin is an ion channel modulator used to treat epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its product, LYRICA was originally developed by Pfizer Ltd. LYRICA was...

July 2021 50 pages

Investigation Report on China's Temozolomide Market 2021-2025 US$ 2,600.00

Temozolomide is a second-generation alkylating agent. It is an oral chemotherapeutic drug used to treat brain cancers such as adult malignant glioma and malignant melanoma. It was developed by Merck &...

July 2021 50 pages

Investigation Report on China's Tigecycline Market 2021-2025 US$ 2,600.00

Tigecycline is a broad-spectrum glycyl cyclic peptide antibiotic administered intravenously. Tigecycline is approved for complicated skin and skin structure infections or complicated intra-abdominal i...

July 2021 50 pages

Research Report on China's Mecobalamin Market, 2021-2025 US$ 2,600.00

Mecobalamin is an endogenous coenzyme B12, which has a good effect on neuronal conduction compared with other types of vitamin B12, and can promote nucleic acid-protein-lipid metabolism through methyl...

July 2021 50 pages

Global Local Anesthesia Drugs Market Size study, by type (Bupivacaine, Lidocaine, Benzocaine, Ropivacaine, Prilocaine, Chloroprocaine, Others) by mode of administration (Injectable, Surface Anesthetic) and Regional Forecasts 2021-2027 US$ 4,950.00

Global Local Anesthesia Drugs Market is valued at approximately USD 2.5 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.91% over the forecast period 2021-2027. Loc...

July 2021 200 pages

Global Over the Counter Analgesics Market Size study, by Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory, Salicylates, Other Analgesics), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) and Regional Forecasts 2021-2027 US$ 4,950.00

Global Over the Counter Analgesics Market is valued at approximately USD 25.1 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.5 % over the forecast period 2021-202...

July 2021 200 pages

Global Vitamin E Market Size study, by Type (Synthetic, Natural (Tocopherol, Tocotrienols)), by Application (Human Nutrition, Functional Food and Beverages, Cosmetics, Animal Nutrition) and Regional Forecasts 2021-2027 US$ 4,950.00

Global Vitamin E Market is valued approximately USD 2117.3 million in 2020 and is anticipated to grow with a healthy growth rate of more than 4.52 % over the forecast period 2021-2027. Vitamin E inclu...

July 2021 200 pages

Lumakras Drug Clinical Insight & Sales Forecast 2026 US$ 2,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. “Lumakras Drug Clinical Insight & Sales Forecast 2026” Report Highlights:NSCLC Targeting...

July 2021 60 pages

Vitamin China E-News US$ 2,916.00

... on the entire vitamin industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the ... Its subsidiary Xinnuowei Pharmaceutical has eventually been approved to be listed. Vitamins China E-News is a monthly published newsletter, which can be downloaded in PDF ...

June 2021 43 pages

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Drugs In Development, 2021 US$ 3,500.00

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Drugs In Development, 2021 SUMMARY According to the recently published report '3 Phosphoinositide Dependent Protein Kinase 1 - Dr...

June 2021 47 pages

5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 US$ 3,500.00

5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin...

June 2021 53 pages

5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 US$ 3,500.00

5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021'; 5-Hydroxytryptamine Recept...

June 2021 85 pages

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Drugs In Development, 2021 US$ 3,500.00

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Drugs In Development, 2021 SUMMARY Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 13 molecules. Out of which approximately 1...

June 2021 68 pages

Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021 US$ 2,500.00

Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease (Central Nervo...

June 2021 2055 pages

Apoptosis Regulator BAX - Drugs In Development, 2021 US$ 3,500.00

Apoptosis Regulator BAX - Drugs In Development, 2021 SUMMARY Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Apoptosis regulator BAX or bcl-2-like protein 4 is a protein is encoded b...

June 2021 46 pages

Arrhythmias (Cardiovascular) - Drugs In Development, 2021 US$ 2,000.00

Arrhythmias (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias (Cardiovascular) - Drugs In Developmen...

June 2021 92 pages

Aryl Hydrocarbon Receptor - Drugs In Development, 2021 US$ 3,500.00

Aryl Hydrocarbon Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Aryl Hydrocarbon Receptor - Drugs In Development, 2021'; Aryl Hydrocarbon Receptor (Class E B...

June 2021 139 pages

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021 US$ 2,500.00

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis - Drugs In De...

June 2021 847 pages

Atrial Fibrillation (Cardiovascular) - Drugs In Development, 2021 US$ 2,000.00

Atrial Fibrillation (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation (Cardiovascular) - Dru...

June 2021 148 pages

Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) - Drugs In Development, 2021 US$ 2,000.00

Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Attent...

June 2021 199 pages

Batten Disease (Central Nervous System) - Drugs In Development, 2021 US$ 2,000.00

Batten Disease (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease (Central Nervous System)...

June 2021 103 pages

Bromodomain Containing Protein 2 - Drugs In Development, 2021 US$ 3,500.00

Bromodomain Containing Protein 2 - Drugs In Development, 2021 SUMMARY According to the recently published report 'Bromodomain Containing Protein 2 - Drugs In Development, 2021'; Bromodomain Containing...

June 2021 82 pages

Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Drugs In Development, 2021 US$ 3,500.00

Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Drugs In Development, 2021 SUMMARY Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) pipeline Target constitutes close to 10...

June 2021 80 pages

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Drugs In Development, 2021 US$ 3,500.00

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Drugs In Development, 2021 SUMMARY Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Bromodomain-containing protein 4 is a protein e...

June 2021 176 pages

Bromodomain Testis Specific Protein - Drugs In Development, 2021 US$ 3,500.00

Bromodomain Testis Specific Protein - Drugs In Development, 2021 SUMMARY Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) pipeline Target constitutes close t...

June 2021 69 pages

Burns (Dermatology) - Drugs In Development, 2021 US$ 2,000.00

Burns (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burns (Dermatology) - Drugs In Development, 2021, provides...

June 2021 142 pages

Calcitonin Gene Related Peptide Type 1 Receptor - Drugs In Development, 2021 US$ 3,500.00

Calcitonin Gene Related Peptide Type 1 Receptor - Drugs In Development, 2021 SUMMARY Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) pipeline Target const...

June 2021 85 pages

Caspase 7 - Drugs In Development, 2021 US$ 3,500.00

Caspase 7 - Drugs In Development, 2021 SUMMARY Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Caspase-7 (CASP7) is a human protein encoded by...

June 2021 56 pages

Cell Division Protein FtsZ (ftsz) - Drugs In Development, 2021 US$ 3,500.00

Cell Division Protein FtsZ (ftsz) - Drugs In Development, 2021 SUMMARY Cell Division Protein FtsZ (ftsz) - FtsZ is a protein encoded by the ftsZ gene. It is essential cell division protein that forms...

June 2021 36 pages

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) - Drugs In Development, 2021 US$ 2,000.00

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gui...

June 2021 96 pages

Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021 US$ 2,000.00

Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis (Infectious Disease)...

June 2021 86 pages

Complex Regional Pain Syndrome (Central Nervous System) - Drugs In Development, 2021 US$ 2,000.00

Complex Regional Pain Syndrome (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Complex Regional Pain S...

June 2021 66 pages

Congestive Heart Failure (Heart Failure) (Cardiovascular) - Drugs In Development, 2021 US$ 2,500.00

Congestive Heart Failure (Heart Failure) (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Fail...

June 2021 760 pages

Filters

Clear all